Company intelligence / Profile preview

ProQuest Investments

Princeton, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

ProQuest Investments manages over $875 million in assets and has made 59 investments with an average round size of $35 million. The firm has 31 exits and a strategy success index of 0.70. Portfolio companies include Pharmion, ReVision Optics, and Aerovance. The firm invests from seed to late-stage and has specialized expertise in therapeutics.

Industry: Investors

Beyond the preview

Go deeper on ProQuest Investments.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ProQuest Investments.

Explore the full profile